Corneal Disease Treatment: Streamlining Phase 1 Trials With The Mobile Vision Pod

A contract research organization, specializing in early-phase drug development, encountered significant challenges during a Phase 1 clinical trial for a corneal disease treatment. Issues such as low patient enrollment, scheduling conflicts with local ophthalmologists, and inadequate space for eye assessments hindered progress. To overcome these obstacles, 20/20 Onsite deployed their Mobile Vision Pod (MVP), a state-of-the-art mobile exam facility designed to enhance patient care and streamline clinical processes.

The MVP, equipped with advanced technology and staffed by trained professionals, facilitated controlled eye exams, improving patient recruitment and retention, optimized workflow, and ensuring data integrity. The Mobile Vision Pod proved instrumental in the success of the clinical trial for corneal disease, showcasing 20/20 Onsite's commitment to developing flexible, high-quality care solutions that address the logistical challenges of clinical research across various therapeutic areas.